The estimated Net Worth of Shu Kwong Ngai is at least $16.1 Thousand dollars as of 19 April 2013. Shu Ngai owns over 43,100 units of IGC Pharma Inc stock worth over $16,141 and over the last 12 years Shu sold IGC stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Shu Ngai IGC stock SEC Form 4 insiders trading
Shu has made over 1 trades of the IGC Pharma Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Shu bought 43,100 units of IGC stock worth $16,141 on 19 April 2013.
The largest trade Shu's ever made was buying 43,100 units of IGC Pharma Inc stock on 19 April 2013 worth over $16,141. On average, Shu trades about 43,100 units every 0 days since 2013. As of 19 April 2013 Shu still owns at least 43,100 units of IGC Pharma Inc stock.
You can see the complete history of Shu Ngai stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Shu Ngai's mailing address?
Shu's mailing address filed with the SEC is PO BOX 60642, , POTOMAC, MD, 20859.
Insiders trading at IGC Pharma Inc
Over the last 17 years, insiders at IGC Pharma Inc have traded over $12,397,736 worth of IGC Pharma Inc stock and bought 1,543,722 units worth $473,972 . The most active insiders traders include Ram Mukunda, Steven Michael Oliveira, and Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of $93,624. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth $443,627.
What does IGC Pharma Inc do?
igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
What does IGC Pharma Inc's logo look like?
Complete history of Shu Ngai stock trades at IGC Pharma Inc
IGC Pharma Inc executives and stock owners
IGC Pharma Inc executives and other stock owners filed with the SEC include:
-
Ram Mukunda,
Exec. Chairman, Pres & CEO -
Claudia Grimaldi,
Vice President, Principal Financial Officer -
Claudia Grimaldi,
VP & Principal Financial Officer -
Richard Prins,
Independent Chairman of the Board -
Rohit Goel,
Manager and Principal Accounting Officer -
Dr. Ranga C. Krishna M.D.,
Sr. Advisor -
Parveen Mukunda,
Corp. Sec. -
Rohit Goel,
Sr. Director of Accounting & Principal Accounting Officer -
John Edward Lynch,
Director -
John Cherin,
CFO, Treasurer and PAO -
Sudhakar V Shenoy,
Director -
Ranga C Krishna,
Director -
Terry L Lierman,
Director -
Shu Kwong Ngai,
Interim CFO -
Zwirn & Co., L.P.Zwirn Dani...,
-
Acquisition Master Fund Ltd...,
10% owner -
Suhail Nathani,
Director -
Ag Ubs,
10% owner -
Steven Michael Oliveira,
10% owner -
Master Fund Ltd. Nisswa,
10% owner -
Ram Mukunda,
CEO -
Strategic Investment Fund A...,
10% owner -
James P Moran,
Director